{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:18:10Z","timestamp":1789499890545,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:p>\n                    Observational studies suggest an association between nonalcoholic fatty liver disease (NAFLD) and liver cancer, but its causal nature remains unclear. A 2-sample Mendelian randomization (MR) analysis was performed using NAFLD and liver cancer summary statistics from genome-wide association study databases. Instrumental variables satisfying the 3 core MR assumptions were selected. Causal effects were estimated using inverse-variance weighted, MR-Egger, weighted median, and other methods, followed by sensitivity and power analyses. All 4 MR analyses demonstrated a positive causal association between NAFLD and liver cancer risk [odds ratio\u2005&gt;\u20051, inverse-variance weighted\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001]. Sensitivity analysis indicated no significant level of multiplicity or heterogeneity in the instrumental variables, and individual single nucleotide polymorphisms had no significant impact on the results. However, statistical power was insufficient. This study provides the first MR evidence demonstrating a genetically predicted causal relationship between NAFLD and liver cancer that is consistent across subtypes. Sensitivity analyses confirmed the absence of horizontal pleiotropy or heterogeneity, strengthening the robustness of the findings. These results offer genetic support for early NAFLD intervention to reduce the risk of liver cancer. However, the limited statistical power highlights the need for larger-scale genome-wide association study to identify more and stronger genetic instruments for a more precise quantification of the causal effect of NAFLD on liver cancer risk.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045125","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:00:29Z","timestamp":1762210829000},"page":"e45125","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between NAFLD and liver cancer: A two-sample Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Feihua","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5245-8650","authenticated-orcid":false,"given":"Xifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Affiliated Hospital of Putian University, Putian, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/livers4010001","article-title":"The pivotal role of the membrane-bound O-acyltransferase domain containing 7 in non-alcoholic fatty liver disease.","volume":"4","author":"Chandrasekaran","year":"2023","journal-title":"Liver"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/ijms20081948","article-title":"Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview.","volume":"20","author":"Marchisello","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study.","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"1422499","DOI":"10.3389\/fmed.2024.1422499","article-title":"Causal relationship between non-alcoholic fatty liver disease and sarcopenia: a bidirectional Mendelian randomization study.","volume":"11","author":"Chen","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 1","key":"R5-20260915","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma.","volume":"73","author":"Mcglynn","year":"2021","journal-title":"Hepatology"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/liv.15195","article-title":"Risk of hepatic and extrahepatic cancer in NAFLD: a population-based cohort study.","volume":"42","author":"Bjorkstrom","year":"2022","journal-title":"Liver Int"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: the growing challenge.","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease.","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.3390\/cancers15225458","article-title":"From non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): epidemiology, incidence, predictions, risk factors, and prevention.","volume":"15","author":"Motta","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jceh.2022.11.006","article-title":"Hepatic, extra-hepatic outcomes and causes of mortality in NAFLD \u2013 an umbrella overview of systematic review of meta-analysis.","volume":"13","author":"Xiao","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"1148934","DOI":"10.3389\/fendo.2023.1148934","article-title":"Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment.","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/HEP.0000000000000319","article-title":"Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-beta\/SMAD signaling.","volume":"78","author":"Song","year":"2023","journal-title":"Hepatology"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","article-title":"Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern.","volume":"149","author":"Dhamija","year":"2019","journal-title":"Indian J Med Res"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/pathogens12070940","article-title":"From non-alcoholic fatty liver disease to liver cancer: microbiota and inflammation as key players.","volume":"12","author":"Rodriguez-Lara","year":"2023","journal-title":"Pathogens"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/cancers16020259","article-title":"MASLD and the development of HCC: pathogenesis and therapeutic challenges.","volume":"16","author":"Phoolchund","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S2468-1253(23)00275-3","article-title":"Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease.","volume":"9","author":"Thomas","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12920-022-01394-7","article-title":"Contribution of PNPLA3 gene polymorphisms to hepatocellular carcinoma susceptibility in the Chinese Han population.","volume":"15","author":"Gong","year":"2022","journal-title":"BMC Med Genomics"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep4.1886","article-title":"The rs429358 locus in apolipoprotein E is associated with hepatocellular carcinoma in patients with cirrhosis.","volume":"6","author":"Innes","year":"2022","journal-title":"Hepatol Commun"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"fcae190","DOI":"10.1093\/braincomms\/fcae190","article-title":"Investigation of the genetic aetiology of Lewy body diseases with and without dementia.","volume":"6","author":"Wu","year":"2024","journal-title":"Brain Commun"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"12947","DOI":"10.3390\/ijms232112947","article-title":"APOE genotypes modulate inflammation independently of their effect on lipid metabolism.","volume":"23","author":"Civeira-Marin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/alz.078698","article-title":"AD risk variants in APOE differentially affect lipid metabolism in iPSC derived neurons, astrocytes and microglia.","volume":"19","author":"Feringa","year":"2023","journal-title":"Alzheimers Demen"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"106490","DOI":"10.1016\/j.sleep.2025.106490","article-title":"Pleiotropic effects of APOE variants on a sleep-based adult epidemiological cohort.","volume":"131","author":"Moyses-Oliveira","year":"2025","journal-title":"Sleep Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:00:35Z","timestamp":1789498835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":26,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045125","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-07-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}